Clinical Trials Browser

Terminated × Observational × Carcinoma, Squamous Cell × Clear all

Carcinoma, Squamous Cell, Lung Neoplasms

NCT04688749 2023-07-25

DermaSense

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Carcinosarcoma, Dysplastic Nevus Syndrome, Melanoma, Neoplasms, Keratosis, Seborrheic, Hutchinson's Melanotic Freckle

NCT03321903 2019-12-19

EPR Tumor Oximetry With CE India Ink

Terminated

3 enrolled

BreastDermatologicHead & Neck

Anthrax, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Melanoma, Neoplasms, Skin Neoplasms

NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Terminated

191 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT01142869 2017-05-08

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Terminated

133 enrolled

Carcinoma, Squamous Cell, Neoplasms, Squamous Cell

NCT01884129 2015-12-10

CTCHNSCC01

Terminated

53 enrolled

Head & Neck

Carcinoma, Squamous Cell, Death, Head and Neck Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Recurrence

Clinical Trials

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

DermaSense

EPR Tumor Oximetry With CE India Ink

Identification of Key Blood Molecular Markers for Immunotherapy

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

CTCHNSCC01